Source: Rheumatology international. Unidade: FM
Subjects: IMUNOGLOBULINAS INTRAVENOSAS, DOENÇAS MUSCULARES, HORMÔNIOS GLICOCORTICOIDES, IMUNOTERAPIA, RESSONÂNCIA MAGNÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Jean Marcos de e HOFF, Leonardo Santos e SHINJO, Samuel Katsuyuki. Intravenous human immunoglobulin and/or methylprednisolone pulse therapies as a possible treat-to-target strategy in immune-mediated necrotizing myopathies. Rheumatology international, v. 39, n. 7, p. 1201-1212, 2019Tradução . . Disponível em: https://doi.org/10.1007/s00296-019-04254-3. Acesso em: 29 set. 2024.APA
Souza, J. M. de, Hoff, L. S., & Shinjo, S. K. (2019). Intravenous human immunoglobulin and/or methylprednisolone pulse therapies as a possible treat-to-target strategy in immune-mediated necrotizing myopathies. Rheumatology international, 39( 7), 1201-1212. doi:10.1007/s00296-019-04254-3NLM
Souza JM de, Hoff LS, Shinjo SK. Intravenous human immunoglobulin and/or methylprednisolone pulse therapies as a possible treat-to-target strategy in immune-mediated necrotizing myopathies [Internet]. Rheumatology international. 2019 ; 39( 7): 1201-1212.[citado 2024 set. 29 ] Available from: https://doi.org/10.1007/s00296-019-04254-3Vancouver
Souza JM de, Hoff LS, Shinjo SK. Intravenous human immunoglobulin and/or methylprednisolone pulse therapies as a possible treat-to-target strategy in immune-mediated necrotizing myopathies [Internet]. Rheumatology international. 2019 ; 39( 7): 1201-1212.[citado 2024 set. 29 ] Available from: https://doi.org/10.1007/s00296-019-04254-3